CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-16 | ANDREWS RONALD ASBURY President & CEO | Purchase | +40,000 | $0.96 | $38K | 333,212 |
| 2022-08-16 | GRIFFITH MELINDA Director | Purchase | +10,000 | $1.00 | $10K | 30,000 |
| 2022-08-16 | Carter Jennifer L. Director | Purchase | +10,500 | $0.95 | $10K | 30,500 |
| 2022-08-16 | Arno Andrew Director | Purchase | +115,523 | $0.97 | $112K | 282,049 |
| 2022-08-15 | Ross Douglas T. Chief Scientific Officer | Grant or award | +150,000 | 170,317 | ||
| 2022-08-15 | Paulsen Gisela President & COO | Grant or award | +175,000 | 191,500 | ||
| 2022-08-15 | Paulsen Gisela President & COO | Grant or award | +350,000 | 541,500 | ||
| 2022-08-15 | Last Andrew J. Director | Grant or award | +10,000 | 50,170 | ||
| 2022-08-15 | Last Andrew J. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2022-08-15 | KINGSLEY ALFRED D Director | Grant or award | +10,000 | 404,111 | ||
| 2022-08-15 | KINGSLEY ALFRED D Director | Purchase | +5,000 | $0.97 | $5K | 409,111 |
| 2022-08-15 | KINGSLEY ALFRED D Director | Purchase | +5,000 | $0.97 | $5K | 414,111 |
| 2022-08-15 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2022-08-15 | John Anish M. Chief Financial Officer | Grant or award | +150,000 | 150,000 | ||
| 2022-08-15 | John Anish M. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +100,000 | 100,000 | ||
| 2022-08-15 | Gutfreund John Peter Director | Grant or award | +10,000 | 10,000 | ||
| 2022-08-15 | Gutfreund John Peter Director | Purchase | +25,000 | $0.93 | $23K | 25,000 |
| 2022-08-15 | Gutfreund John Peter Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2022-08-15 | GRIFFITH MELINDA Director | Grant or award | +10,000 | 20,000 | ||
| 2022-08-15 | GRIFFITH MELINDA Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 |
Page 8 of 12 · 222 trades